5000272025-04-012025-06-305000272025-06-305000272025-04-012025-06-30in-capmkt:OtherExpenses1Member5000272025-04-012025-06-30in-capmkt:OtherExpenses2Member5000272025-04-012025-06-30in-capmkt:ReportableSegments1Member5000272025-04-012025-06-30in-capmkt:ReportableSegments2Member5000272025-04-012025-06-30in-capmkt:ReportableSegments3Member5000272025-04-012025-06-30in-capmkt:ReportableSegments1Member5000272025-04-012025-06-30in-capmkt:ReportableSegments2Member5000272025-04-012025-06-30in-capmkt:ReportableSegments3Member5000272025-04-012025-06-30in-capmkt:ReportableSegments1Member5000272025-06-30in-capmkt:ReportableSegments1Member5000272025-04-012025-06-30in-capmkt:ReportableSegments2Member5000272025-06-30in-capmkt:ReportableSegments2Member5000272025-04-012025-06-30in-capmkt:ReportableSegments3Member5000272025-06-30in-capmkt:ReportableSegments3Member5000272025-04-012025-06-30in-capmkt:ReportableSegments1Member5000272025-06-30in-capmkt:ReportableSegments1Member5000272025-04-012025-06-30in-capmkt:ReportableSegments2Member5000272025-06-30in-capmkt:ReportableSegments2Member5000272025-04-012025-06-30in-capmkt:ReportableSegments3Member5000272025-06-30in-capmkt:ReportableSegments3Member5000272025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15000272025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25000272025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss15000272025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss2iso4217:INRiso4217:INRxbrli:shares500027ATULNOTLISTEDINE100A01010ATUL LIMITEDMain BoardEquity2025-04-012026-03-312025-07-182025-06-26INRCroresQuarterlyFirst quarterMulti segment2025-07-1810:00:002025-07-1813:15:00Not applicable2025-04-012025-06-30UnauditedConsolidated14780000000262400000150424000007910900000195700000-5207000001200200000454000008204000003638900000132908000001751600000017516000003706000007610000044670000001304900000000187000001323600000176540000030890000001277700000459000003043100000459000002944000001043.443.40043.443.41. These results have been prepared in accordance with the Indian Accounting Standard (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. <BR> <BR> 2. These results have been reviewed and recommended for adoption by the Audit Committee in its meeting held on July 17, 2025 and approved by the Board of Directors in its meeting held on July 18, 2025. The Statutory Auditors have carried out limited review of the consolidated unaudited financial results for the quarter ended on June 30, 2025. Their limited review report does not have any modification. <BR> <BR> 3. The Company has reported segment information as per the Ind AS 108, 'Operating Segments', as below: <BR> <BR> Name of segment Main product groups <BR> Life Science Chemicals Active pharmaceutical ingredients and its intermediates, crop protection chemicals <BR> Performance and Other Chemicals Adhesion promoters, bulk chemicals, epoxy resins and hardeners, intermediates, textile dyes <BR> Others Agribiotech, food products, services and others <BR> <BR> 4. Other expenses include ` 24.56 cr for the quarter ended and ` 41.36 cr for the year ended on March 31, 2025 towards application fees, cess, premium, conversion charges, customary penal charges, non-agricultural assessment charges, differential stamp duty, etc, for converting part of the agricultural land to industrial use. <BR> <BR> 5. The figures for the quarter ended on March 31, 2025 are the balancing figures between audited figures for the full financial year and the published year-to-date figures up to the third quarter. <BR> Power, fuel and water1832200000Other Expenses1806700000Life Science Chemicals4492000000Performance and Other Chemicals10669300000Others1636000001532490000054490000014780000000Life Science Chemicals684100000Performance and Other Chemicals1000000000Others23400000170750000045400000-1082000001770300000Life Science Chemicals13045300000Performance and Other Chemicals37004100000Others2290500000523399000002269440000075034300000Life Science Chemicals3287100000Performance and Other Chemicals8061900000Others244800000115938000003724700000153185000001. These results have been prepared in accordance with the Indian Accounting Standard (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. <BR> <BR> 2. These results have been reviewed and recommended for adoption by the Audit Committee in its meeting held on July 17, 2025 and approved by the Board of Directors in its meeting held on July 18, 2025. The Statutory Auditors have carried out limited review of the consolidated unaudited financial results for the quarter ended on June 30, 2025. Their limited review report does not have any modification. <BR> <BR> 3. The Company has reported segment information as per the Ind AS 108, 'Operating Segments', as below: <BR> <BR> Name of segment Main product groups <BR> Life Science Chemicals Active pharmaceutical ingredients and its intermediates, crop protection chemicals <BR> Performance and Other Chemicals Adhesion promoters, bulk chemicals, epoxy resins and hardeners, intermediates, textile dyes <BR> Others Agribiotech, food products, services and others <BR> <BR> 4. Other expenses include ` 24.56 cr for the quarter ended and ` 41.36 cr for the year ended on March 31, 2025 towards application fees, cess, premium, conversion charges, customary penal charges, non-agricultural assessment charges, differential stamp duty, etc, for converting part of the agricultural land to industrial use. <BR> <BR> 5. The figures for the quarter ended on March 31, 2025 are the balancing figures between audited figures for the full financial year and the published year-to-date figures up to the third quarter. <BR> Fair value of equity instruments through other comprehensive income2024600000Remeasurement gain | (loss) on defined benefit plans-524000001972200000276100000Effective portion of gain | (loss) on cashflow hedges-800000Exchange differences on translation of foreign operations755000007470000054000001765400000